COMP <GO>
EPD vs CVX // FORWARD P/E MULTIPLE
Enterprise Products Partners L.P. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: EPD 7
— CVX 8
▲ FORWARD P/E MULTIPLE LEADER: EPD
LAST: $38.15 (-2.30%) • MKT CAP: $84.33B
forward-pe
13.5x
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
forward-pe
34.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPD VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPD | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.70% | 41.30% | -14.60 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.90% | 5.80% | +2.10 | EPD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.5x | 21.5x | -9.00 | EPD | /valuation <GO> |
| Free Cash Flow Yield | 7.37% | 5.61% | +1.76 | EPD | /fcf-yield <GO> |
| Operating Margin | 13.80% | 8.10% | +5.70 | EPD | /operating-margins <GO> |
| Net Profit Margin | 11.00% | 6.70% | +4.30 | EPD | /net-margins <GO> |
| Revenue Growth (YoY) | -6.40% | -4.60% | -1.80 | CVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.64 | 3.71 | -1.07 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 7.10% | -0.20 | EPD | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 72.8 | -14.77 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 1.07 | -0.06 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 13.5x | 34.6x | -21.10 | EPD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $84.33B | $457.31B | -$372.98B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPD REV | CVX REV | EPD GROSS % | CVX GROSS % | EPD FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.60B | $184.43B | 26.7% | 41.3% | $6.22B | $25.64B |
| FY 2024 | $56.22B | $193.41B | 24.3% | 38.4% | $3.57B | $22.79B |
| FY 2023 | $49.72B | $196.91B | 44.0% | 44.0% | $5.33B | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPD // BETA 1.01
CVX // BETA 1.07